These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 36085376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K, Pakalniskis MG, Leite LV, Lee DK, Holanda DG, Rajput M.
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [Abstract] [Full Text] [Related]

  • 5. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, Johnson PT, Fishman EK, Allaf ME.
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Morphologic analysis with computed tomography may help differentiate fat-poor angiomyolipoma from renal cell carcinoma: a retrospective study with 602 patients.
    Kim YH, Han K, Oh YT, Jung DC, Cho NH, Park SY.
    Abdom Radiol (NY); 2018 Mar; 43(3):647-654. PubMed ID: 28677004
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiomyolipoma with minimal fat: differentiation from papillary renal cell carcinoma by helical CT.
    Zhang YY, Luo S, Liu Y, Xu RT.
    Clin Radiol; 2013 Apr; 68(4):365-70. PubMed ID: 23321146
    [Abstract] [Full Text] [Related]

  • 10. Differentiation between papillary renal cell carcinoma and fat-poor angiomyolipoma: a preliminary study assessing detection of intratumoral hemorrhage with chemical shift MRI and T2*-weighted gradient echo.
    Woo S, Kim SY, Cho JY, Kim SH.
    Acta Radiol; 2018 May; 59(5):627-634. PubMed ID: 29069911
    [Abstract] [Full Text] [Related]

  • 11. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X, Nie P, Zhang J, Hou F, Ma Q, Cui J.
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [Abstract] [Full Text] [Related]

  • 12. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K, Takahashi N, Gomez-Cardona D, Leng S, Schmit GD, Carter RE, Leibovich BC, Kawashima A.
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [Abstract] [Full Text] [Related]

  • 13. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
    Qu JY, Jiang H, Song XH, Wu JK, Ma H.
    Diagn Interv Radiol; 2023 Mar 29; 29(2):205-211. PubMed ID: 36960636
    [Abstract] [Full Text] [Related]

  • 14. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation.
    Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y.
    Abdom Radiol (NY); 2022 Jun 29; 47(6):2178-2186. PubMed ID: 35426498
    [Abstract] [Full Text] [Related]

  • 15. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH, Kim CS, Kim MJ, Cho JY, Cho SH.
    AJR Am J Roentgenol; 2016 Jan 29; 206(1):W21-8. PubMed ID: 26700359
    [Abstract] [Full Text] [Related]

  • 16. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS.
    Radiology; 2013 May 29; 267(2):444-53. PubMed ID: 23382290
    [Abstract] [Full Text] [Related]

  • 17. Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.
    Varghese BA, Chen F, Hwang DH, Cen SY, Desai B, Gill IS, Duddalwar VA.
    AJR Am J Roentgenol; 2018 Dec 29; 211(6):W288-W296. PubMed ID: 30240299
    [Abstract] [Full Text] [Related]

  • 18. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
    Paschall AK, Mirmomen SM, Symons R, Pourmorteza A, Gautam R, Sahai A, Dwyer AJ, Merino MJ, Metwalli AR, Linehan WM, Malayeri AA.
    Abdom Radiol (NY); 2018 Sep 29; 43(9):2424-2430. PubMed ID: 29520425
    [Abstract] [Full Text] [Related]

  • 19. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
    Kang HS, Park JJ.
    Korean J Radiol; 2021 May 29; 22(5):735-741. PubMed ID: 33660463
    [Abstract] [Full Text] [Related]

  • 20. Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study.
    Luo S, Lin W, Wu J, Zhang W, Kui X, Lai S, Wei R, Pang X, Wang Y, He C, Liu J, Yang R.
    Acad Radiol; 2024 Apr 29; 31(4):1460-1471. PubMed ID: 37945492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.